Table 3.
Changes between baseline and 12-week measurements.
| Test group (n = 25) | Placebo group (n = 26) | p value | |
|---|---|---|---|
| Fasting glucose, mg/dL | 1.12 ± 6.67 | 1.50 ± 5.95 | 0.832 |
| Plasma insulin, μU/dL | 0.30 ± 5.91 | −0.04 ± 2.12 | 0.788 |
| HbA1c, % | −0.24 ± 0.27 | 0 ± 0.23 | 0.737 |
| Triglyceride, mg/dL | 24.88 ± 92.15 | −4.16 ± 27.54 | 0.131 |
| Total cholesterol, mg/dL | 0 ± 20.21 | 4.46 ± 18.54 | 0.415 |
| LDL cholesterol, mg/dL | −3.20 ± 20.99 | 1.85 ± 17.16 | 0.351 |
| HDL cholesterol, mg/dL | −1.72 ± 8.34 | 0 ± 7.58 | 0.444 |
Data are expressed as mean ± standard deviation.
p values were calculated with Student's t-test for continuous variables.
LDL, low density lipoprotein; HDL, high density lipoprotein.